PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10363493-5	1999	RESULTS: Donepezil is a specific, reversible acetylcholinesterase inhibitor of close to 100% absorption and a half-life of 70 h, achieving stable concentrations at approximately 3 weeks.	Donepezil	9-18	acetylcholinesterase (Cartwright blood group)	Homo sapiens	45-65	
10363493-12	1999	CONCLUSIONS: Different studies carried out with the acetylcholinesterase inhibitors donepezil, rivastigmine and metriphonate have been effective in the control of the cognitive symptoms of Alzheimer disease in the initial or moderate phases of the disease.	Donepezil	84-93	acetylcholinesterase (Cartwright blood group)	Homo sapiens	52-72